ACSM’s comprehensive sports medicine and exercise science conference takes place virtually from June 1 to 5 with programming covering the science, practice, public health and policy aspects of sports medicine, exercise science and physical activity.
New Approach Methodologies (NAMs) can quickly and efficiently collect a large amount of information about the potential toxicity of chemicals without the use of intact animals, but there are challenges to using them to evaluate developmental toxicity compared with adult…
Treatment options for many types of cancers remain limited, due partly to the in vitro tools used to model cancers and that results from animal studies do not always translate well to human disease. These shortcomings point to a clear need for a better, patient-specific model. Researchers suggest bioengineered microscale organotypic models can address this need. They discuss the advantages and capabilities of this technique, as well as its challenges, in the journal APL Bioengineering.
A Lawrence Livermore National Laboratory team, along with their collaborators, has become the first to produce a living, bioprinted aneurysm outside of the human body, perform a medical procedure on it, and observe it respond and heal as it would in an actual human brain.
In addition to research exploring such areas as biomarkers, nano- and neurotoxicology, and developmental and reproductive toxicology, the January 2020 issue of Toxicological Sciences features a new article category, ToxPoint, to underscore cutting-edge topics in toxicology.
Randox Quality Control is set to introduce its brand new Acusera Infectious Disease (Serology) Controls at the American Association for Clinical Chemistry 2019.
A ground-breaking new test which improves the accuracy of stroke diagnosis has been developed by Randox scientists.